Aquestive Therapeutics, Inc. Common Stock

AQST XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

460M

Short interest (Jul 15)

13.3%

Net Short (Jul 27 ): 0.1%

Borrow Fee

0.71%

↑ 2.2%

Available Shares

700K

↑ 44.0%

Price Chart

Company Overview

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001398733

Asset Type: CS

Market Data

Market Cap: $461,718,515

Employees: 147

Status: Active

Short Interest

Current Borrow Fee 0.71%

Range: 0.71% - 0.85%

Available Shares 700K

Range: 400K - 650K

Recent Changes

Fee Change: ↑ 16.5%

Available Change: ↑ 85.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime